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strate the application of our freely available Microsoft-Excel based tool using an 
example of a network meta-analysis of anti-platelet agents in patients scheduled 
for percutaneous coronary inteventions. ConClusions: Use of this freely available 
Microsoft-Excel based tool successfully demonstrated its ability to make running 
network meta-analyses more accessible to novice WinBUGS users, and facilitate 
more transparent critical appraisal of network meta-analyses.
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objeCtives: In order to examine comparative research questions using data from a 
naturalistic, observational study (REACH-OUT) of adult patients with schizophrenia, 
non-traditional methods were needed. This abstract describes the use of multiple 
control groups to maximize inclusion of paliperidone palmitate (PP) patients in 
REACH-OUT who would otherwise be excluded from analysis due to poor propensity 
score matching with registry controls (patients receiving oral atypical antipsychotics 
(OAT)). The matched cohorts (PP and combined OAT) will be used in future resource 
use comparisons. Methods: Because matching on propensity of PP treatment did 
not yield an adequate number of matched registry controls, a secondary set of 
OAT controls was extracted from MarketScan® claims data. PP patients unmatched 
to registry controls were matched to claims controls using a 1:1 propensity score 
matching. Post-match baseline characteristics for the PP and combined OAT cohort 
were examined using descriptive statistics. Outcomes from the claims-based control 
group will be adjusted for source bias based on 500 simulations, according to the 
Stuart-Rubin (S-R) methodology. Results: Out of 354 PP with non-missing baseline 
data, 190 were matched to registry controls and the remaining 164 were matched 
to the supplemental control group. The final matched PP and OAT cohorts were 
balanced in observed attributes such as age (41.4 years vs. 42.0, p= 0.552), gender 
distribution (70.3% vs. 65.5% male, p= 0.171), ≥ 1 baseline hospitalization (29.7% vs. 
34.5%, p= 0.171), and ≥ 1 baseline ER visit (31.1% vs. 35.6%, P= 0.202), respectively. 
Initial S-R simulations suggest outcomes for the supplemented control group are 
similar to the cohort of all REACH-OUT controls (e.g., 6 month admission rates, 18.9% 
and 22.6%, respectively). ConClusions: Use of multiple control groups permitted 
successful propensity score matching of all registry PP patients allowing for greater 
power, better precision, and increased external validity in the forthcoming analysis 
of the treatment effect of PP.
ReseaRch on Methods – study design
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objeCtives: Logistic regression is widely used to assess the likelihood of an infec-
tious disease as a function of a risk or exposure factor (and covariates), to illustrate 
the exposure-response relationship. However, because the exposure of patients 
with infectious disease is an intricate net instead of independent factors, the sta-
tistical power of logistic regression may be compromised leading to an inaccurate 
conclusion. Therefore, this study aims to examine the statistical power of logistic 
regression using simulated data of infectious disease. Methods: A dynamic human 
immunodeficiency virus (HIV) infection was simulated among 10000 individuals 
with 1% initial prevalence and 7% target prevalence. Monte Carlo simulation method 
was used to examine the statistical powers of regular logistic regression (grouping 
sexual partners into 0-2, 3-5, 6-8, 9-11, 12-14 and ≥ 15), transformed logistic regres-
sion (using log[1+number of sexual partners]) and negative binomial regression 
on estimating the risk of HIV infection along with increasing number of unpro-
tected sexual partners. Results: Regular logistic regression had poor statistical 
power and overestimated the odds ratio (OR) when the number of sex partner was 
more than 11 (power was 78% for 12-14 partners and only 4% for over 14 partners). 
Transformed logistic regression overstated the odds ratio even while the number 
of sex partner was small. Negative binomial regression had 100% power finding the 
association between HIV infection and the number of sexual partners, yet it was not 
available to provide odds ratio. ConClusions: Due to the diverse distribution of 
exposure in infectious disease (negative binomial), evaluations that include logistic 
regression, to explore the exposure-response relationship, provide improved rigor 
to base decisions.
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objeCtives: A US medical claims-based analysis was designed to evaluate bur-
den of illness associated with narcolepsy, a chronic, non-progressive disease often 
presenting early in life. Because diagnostic testing for narcolepsy is not normally 
repeated, objective evidence of a diagnosis would be absent for many patients in a 
time-limited data set. Therefore, internal validation of a study population selected 
using diagnosis codes was performed. Methods: Within the 5-year data collec-
tion period (2006 through 2010), 9312 continuously insured adult patients were 
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objeCtives: To develop and test a new method of estimating the ICER utilizing 
the harmonic mean. Methods: A statistically-efficient point and 95% confidence 
interval (CI) estimator of the ICER was derived that utilized the harmonic mean of 
costs and effects, hence applying the inverse of the mean of the inverses for use 
in statistical summarization. An additional correction factor developed through 
computational intelligence was also incorporated to capture existing information 
from the usual bootstrap ICER estimator. A simulation study of 1111 replications 
with 999 bootstrap resamples each utilizing Matlab R2012b was undertaken across 
illustrative positive and negative correlation structures of costs and outcomes for 
varying sample sizes of treatment and referent groups. Results were presented as 
relative efficiencies for point estimators, while coverage probability, coverage error, 
length, left and right bias, and relative bias were presented for the 95% CI. Results: 
Compared to the usual bootstrap approach, optimal methods based upon the har-
monic mean yielded point estimates with greater relative efficiency across all ana-
lytic scenarios, ranging from 103.22% to 111.03%. The 95% CI coverage error was 
also consistently lower, deviating from the population value by 0.0005 to 0.0257 
versus the usual bootstrap range of 0.0031 to 0.0302. Thus, an improved shortening 
of the CI length was found across all cases. The maximum relative bias of the new 
estimator was 0.7714 versus 0.2703, which reflected a somewhat higher left bias 
and lower right bias among positive correlation structures, and a greater right bias 
and lesser left bias among negative correlation structures. ConClusions: The new 
approach to estimate the ICER that utilized the harmonic mean allowed for more 
statistically-efficient point estimation. The 95% CIs presented with less coverage 
error and shorter lengths, though typically at the cost of a potential increase in 
relative bias.
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objeCtives: First, to summarize the methodological literature on the correction 
of overall survival for the impact of crossover. Second, to examine and compare 
the use of these statistical methods in cost-effectiveness analyses (CEAs). Third, 
to apply recommended statistical methods to correct overall survival in a clini-
cal trial that included crossover. Methods: Medline, Embase, NHSEED and HEED 
databases, along with grey literature were searched for methodological evidence 
on the appropriate use of survival adjustment, including but not limited to, Inverse 
Probability of Censor Weighting (IPCW) and Rank Preserving Structural Failure Time 
Modelling (RPSFT). In addition, empirical CEAs that applied survival adjustment 
were identified and reviewed. The appropriate methods were applied to a trial with 
crossover to compare IPCW, RPSFT, intention to treat (ITT) and per protocol (PP) 
analysis. Results: The choice of IPCW or RPSFT depends on six factors: common 
treatment effect, true treatment effect, crossover percentage, disease severity, time 
dependence of treatment effect, and crossover mechanism. Nine placebo-controlled 
CEAs that applied survival adjustment were identified: two studies used one method 
without comparison, one study incorporated censor weighting for a meta-analysis, 
five studies reported one method and compared to either ITT or PP analysis, one 
as the primary analysis and four as sensitivity analysis. Only one study reported 
a comparison of multiple methods, IPCW and RPSFT. Empirically, PP, RPSFT and 
IPCW produce lower hazard ratios than ITT. Ranking of PP, RPSFT and IPCW varied 
by the factors. None of the six factors were discussed thoroughly in the empirical 
results. Based on the trial, all patients that crossed-over survived which violates the 
assumptions of common treatment effect for RPSFT and different disease severity 
for IPCW and RPSFT. ConClusions: Applying the six factors guides the a priori 
assessment of appropriate choice of crossover method. In this case, neither IPCW 
or RPSFT were appropriate.
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objeCtives: The role of network meta-analyses has increased dramatically in 
recent years. WinBUGS has been the most widely used software to conduct net-
work meta-analyses. However, the learning curve for using WinBUGS to conduct 
network meta-analyses successfully can be daunting, especially for new users. 
Further, critically appraising network meta-analyses conducted in WinBUGS is chal-
lenging given the limited data analysis and graphical output fromWinBUGS, thus 
network meta-analyses often rely on different software packages. The objective is 
to develop a tool which 1.) makes running network meta-analyses more accessible 
to novice WinBUGS users; and 2.) facilitates a more transparent and efficient critical 
appraisal of network meta-analyses. Methods: We developed a freely available 
Microsoft-Excel based tool, programmed in Visual Basic for applications within 
Excel, which provides an interface for conducting a network meta-analysis using 
WinBUGS from within Microsoft Excel. This tool allows the user to modify assump-
tions and to run the network meta-analysis, and results are returned to an Excel 
spreadsheet. The tool displays the data, evidence networks, forest plots, rankograms, 
and inconsistency plots all entirely within Microsoft Excel. Results: We demon-
